화일약품
6,060KRWMarket close of 10/21 (Wed)
Up +1.17%+70KRWMarket close of 10/21 (Wed)
- Open
- 5,990
- High
- 6,120
- Low
- 5,930
- Day range
- Day range low 5,930 high 6,120, open 5,990, close 6,060, previous close 5,990
- Volume
- 1×10K shares
- 69.69 million KRW 0.23× the 20-session average
Market close of 10/21 (Wed)
Usual range
Nothing unusual in the 3 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsnot verifiedThe last four quarters are incomplete, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 3 are within the usual range
- Daily move+1.17%usual range
- Trading value0.2×usual range
- Data date10/21 (Wed)Market close
See the full check report
Filings in the last 2 years · 1
Material events are checked for the top 400 stocks only — this stock shows periodic reports only.
- 2026-08-13Half-year report (2026.06)
Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 25 days
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.